Synopsis
Glycogen is the main energy store in the
human body, while its concentration is particularly abundant in muscle tissue. In vivo 13C MRS is unique for
investigating glycogen metabolism, as it allows the non-invasive measurement of
natural abundance glycogen C1 resonance in the human muscle. However,
spatial localization is desirable to detect glycogen C2-C6
resonances due to their overlap with the glycerol C2 and C1,
C3 resonances. In this study, we designed a pulse-acquire sequence
for localized 13C MRS using ISIS-1D and OVS schemes. The
localization performance of the sequence was validated in vitro and in vivo in
human muscle at 7T.
Introduction
In vivo
13C MRS provides unique insight into
carbohydrate metabolism, such as the detection of natural abundance glycogen C
1
resonance in human muscle [1]. Nonetheless,
the un-localized
13C spectra are dominated by intense
13C
signals from subcutaneous adipose tissue [2], introducing
baseline distortion and rendering difficult the detection of small
13C
signals, such as the glycogen C
2-C
6 resonances due to their
overlap with the glycerol C
2 and C
1,C
3
resonances [3]. Localized
13C MRS
allows to remove the unwanted signal while the use of high magnetic field
strength benefits from an improved signal to noise ratio (SNR) and spectral
resolution, leading to an increased sensitivity and separation of carbon
resonances [4]. Therefore, the aim of this
study was to design a pulse-acquire sequence for localized
13C MRS
using OVS and ISIS-1D schemes based on earlier reports [5, 6], and test the efficiency of distinct detection of glycogen
C
2-C
6 resonances in
vitro and in vivo in human muscle at 7T within SAR limitation.
Methods
All experiments were performed on a 7T
human MR scanner (Siemens Erlangen / Germany) with a
13C-linear /
1H-quadrature
RF surface coil (6cm diameter
13C-loop combined with 9cm diameter
1H-loops).
A small sphere (7mm diameter) containing 99%
13C-enriched formic
acid was placed in the centre of the
13C-linear coil as an external
reference. A pulse-acquire sequence for localized
13C MRS was designed
with OVS and ISIS-1D [5, 6] schemes (Figure 1). In order to reduce the chemical shift
displacement error, localization was applied using hyperbolic secant (HS)
pulses of 5ms duration resulting in a 7kHz bandwidth (Figure 2), larger than
the chemical shift range of the glycogen C
2-C
6 resonances
(1.3 kHz). Localization was followed by symmetric
adiabatic
13C excitation using two adiabatic half passage (AHP)
pulses (2ms, 650Hz symmetric bandwidth) with inverted phases in alternate scans
[7]. The WALTZ16 scheme [8] was applied
during
13C signal acquisition for broadband
1H-decoupling
(90° pulse duration=0.9ms, resulting in a decoupling bandwidth of 600Hz),
while the NOE scheme was applied prior to
localization to achieve
13C signal enhancement (10 NOE pulses (pulse
duration/delay=1/100ms)). The localization performance of the sequence was
validated in vitro on a two-compartment phantom containing 800mM natural
abundance glycogen (inner-compartment) and sunflower oil (outer-compartment).
Three separate in vitro experiments were performed: 1) without localization, 2)
with ISIS-1D localization in a slice parallel to the
13C coil
plane, and 3) with ISIS-1D and three OVS double-bands
((VOI=70x30x30mm
3), TR=1.19ms, 1000 averages, vector size=2048,
BW=20kHz, decoupling duration=21ms, acquisition time=102ms). To validate
the performance of the sequence, localized
13C MR spectra were
acquired in vivo on the human calf of two healthy male volunteers who gave
informed consent according to the
procedure approved by the local ethics committee. Localization was applied in vivo using
ISIS-1D (coronal slice parallel to the
13C coil plane) and two OVS double-bands
((2 transversal and 2 sagital), VOI=80x60x40mm
3, TR=1s, 3000
averages, vector size=2048, BW=20kHz, decoupling duration=21ms,
acquisition time=102ms). All in vitro and in vivo
13C spectra were
acquired using the glycerol C
2 resonance at the centre of the
spectrum. First and second
order shim were adjusted using FAST(EST)MAP [9] with VOI=80x60x40mm
3.
Results
Shimming resulted in a water line-width of 25
Hz. Un-localized
13C MRS in vitro (Figure 3-a) revealed peak
resonances in agreement with the literature [2, 3]. Localized
13C MRS
in vitro (Figure 3-c) demonstrated efficient suppression of glycerol C
2
(69.5ppm) and C
1,C
3 (61.4ppm) resonances using both OVS
and ISIS-1D schemes, allowing simultaneous detection of well resolved carbons
of glycogen C
4 (78ppm) and C
6 (61ppm), and clustered
carbons of glycogen C
3 (74ppm) and C
2,C
5
(72.2ppm), in contrast to that using only ISIS-1D scheme (Figure 3-b) in which
localization was incomplete. Furthermore, the baseline appeared to be improved when
using localization. Localized
13C MRS in vivo revealed well resolved glycogen C
2-C
6
resonances (Figure 4), while some glycerol C
2
and C
1,C
3 remained in the muscle, ascribed to the
presence of intra- and extra-myocellular lipids in muscle and interstitial
adipose tissue, respectively [6]. In addition, the localization sequence efficiently suppressed the intense
lipid resonance at 130 ppm, as no residual lipid signal was observed on the
13C localized in vivo spectrum (Figure 5).
Conclusion
We
conclude that localized
13C MRS is feasible at 7T using an optimized
pulse-sequence including both OVS and ISIS-1D schemes for
13C
localization followed by symmetric adiabatic
13C excitation,
resulting in efficient suppression of glycerol C
2 and C
1,C
3
resonances, as well as intense lipid
resonance at 130 ppm, and this will allow further
extension of this technique for
13C MRS measurements such as in
human brain.
Acknowledgements
This
study was supported by Centre d’Imagerie BioMédicale (CIBM) of the UNIL, UNIGE, HUG,
CHUV, EPFL and the Leenaards and Jeantet Foundations.References
[1] Avison M.J. et al, PNAS 1988; 85(5):1634-6.
[2]
Heerschap A. et al, NRM Biomed. 1989; 2(3):124-32.
[3] Gruetter R. et al, MRM
1994; 31:583-588.
[4] Gruetter R. et al, NMR Biomed
2003;16:313-338.
[5] Tkac I. et al, App. Magn. Reson.
2005; 29:139-157.
[6] Oz G. et al, Appl. Magn. Reson. 2005; 29, 159-169.
[7] Serés Roig E. et al, 2014 ISMRM/ESMRMB.
[8] Shaka
A.J. et al, JMR 1983; 53:313-340.
[9] Gruetter R. et al, MRM 1993; 29, 804-811.